Boehringer Ingelheim Investigational Site

Indianapolis, Indiana 46202

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed
• Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed